Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(7):540-541; doi:10.1093/jnci/dji088
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Wolf, D.
Right arrow Articles by Gunsilius, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolf, D.
Right arrow Articles by Gunsilius, E.
Related Collections
Right arrowResponse to this Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

CORRESPONDENCE

Re: Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents

Dominik Wolf, Holger Rumpold, Ruth Koeck, Eberhard Gunsilius

Affiliation of authors: Department of Hematology and Oncology, Medical University Innsbruck, Innsbruck, Austria

Correspondence to: Eberhard Gunsilius, MD, Laboratory of Angiogenesis and Tumor Biology, Department of Hematology and Oncology, Medical University Innsbruck, Anichstr. 35, 6020 Innsbruck, Austria (e-mail: eberhard.gunsilius@uibk.ac.at).

The first 10% of the full text of this article appears below.

In the November 3, 2004, issue of the Journal, Studeny et al. (1) showed intriguing data on the use of human bone marrow (BM)–derived mesenchymal stem cells (MSCs) for the selective delivery of interferon {beta} (IFN-{beta}) to pulmonary metastases. However, we have concerns . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Response to this Correspondence

RESPONSE: Re: Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents
Frank Marini, Matus Studeny, and Michael Andreeff
J Natl Cancer Inst 2005 97: 541-542. [Extract] [Full Text] [PDF]